PULMONARY TRICHOSPORONOSIS

PULMONARY TRICHOSPORONOSIS was reported 23 times

These drug classes are most commonly taken by patients reporting PULMONARY TRICHOSPORONOSIS:

# Drug Count
0 Corticosteroid [EPC] 13
1 Glycopeptide Antibacterial [EPC] 10
2 Echinocandin Antifungal [EPC] 8
3 Interleukin-6 Receptor Antagonist [EPC] 8
4 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 8
5 Nitroimidazole Antimicrobial [EPC] 7
6 Azole Antifungal [EPC] 5
7 Alkylating Drug [EPC] 4
8 Aminoglycoside Antibacterial [EPC] 4
9 Fluoroquinolone Antibacterial [EPC] 3
10 Penem Antibacterial [EPC] 3
11 Bile Acid [EPC] 2
12 Histamine-1 Receptor Antagonist [EPC] 2
13 Insulin Analog [EPC] 2
14 Lipid-based Polyene Antifungal [EPC] 2
15 Osmotic Laxative [EPC] 2
16 Polyene Antifungal [EPC] 2
17 Purine Antimetabolite [EPC] 2
18 Recombinant Human Deoxyribonuclease 1 [EPC] 2
19 Vitamin C [EPC] 2
20 Aminosalicylate [EPC] 1
21 Angiotensin 2 Receptor Blocker [EPC] 1
22 Antimetabolite Immunosuppressant [EPC] 1
23 BCL-2 Inhibitor [EPC] 1
24 CD20-directed Cytolytic Antibody [EPC] 1
25 Calcium Channel Blocker [EPC] 1
26 Dihydropyridine Calcium Channel Blocker [EPC] 1
27 Folate Analog Metabolic Inhibitor [EPC] 1
28 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
29 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
30 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
31 Human Immunoglobulin G [EPC] 1
32 Lipopeptide Antibacterial [EPC] 1
33 Microtubule Inhibitor [EPC] 1
34 Nucleoside Metabolic Inhibitor [EPC] 1
35 Platinum-based Drug [EPC] 1
36 Tetracycline-class Antibacterial [EPC] 1
37 Tetracycline-class Drug [EPC] 1
38 Tumor Necrosis Factor Blocker [EPC] 1